The use of amisulpride in schizophrenic patients with resistant symptomatology
نویسندگان
چکیده
Materials and methods The material of this study was 21 patients (17 men and 4 women) who were diagnosed with schizophrenic disorder paranoid type based on DSM-IV, and were recorded with durable symptomatology (delusions, paranoid ideas etc.) even though the continuous issuing of Amisulpride in normal doses (800-1200 mg/daily). In these patients was given Amisulpride in larger doses than the proposed (1600-2000 mg/daily). The evaluation was done with the PANSS scale
منابع مشابه
The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open- label study
BACKGROUND The efficacy of antipsychotics can be evaluated using the dimensional models of schizophrenic symptoms. The D2/D3-selective antagonist amisulpride has shown similar efficacy and tolerability to other atypical antipsychotics. The aim of the present study was to determine the efficacy of amisulpride on the dimensional model of schizophrenic symptoms and tolerability in latin schizophre...
متن کاملCabergoline-induced psychotic exacerbation in schizophrenic patients.
INTRODUCTION Hyperprolactinemia is a well-recognized side effect of antipsychotic treatment. Cabergoline, a dopamine agonist, has been introduced on the market to treat hyperprolactinemia, even secondary to antipsychotic use. CASE REPORT In this article, we described two schizophrenic patients who received cabergoline to treat their antipsychotic-induced hyperprolactinemia and developed a sub...
متن کامل[Augmentation strategies in patients with schizophrenia who show partial response to clozapine treatment].
A significant proportion of patients with schizophrenia receiving clozapine remain with partial response. In this group of patients findings regarding addition of various psychotropics to ongoing clozapine treatment for augmentation are controversial. In this review, literature regarding the efficacy and safety of adjunctive agents in clozapine resistant schizophrenic patients is examined. Augm...
متن کاملClozapine resistance: augmentation strategies.
BACKGROUND Clozapine (CLZ) is not effective in more than 50% of treatment-resistant schizophrenic patients. In these cases, several pharmacological strategies are used in clinical practice, with different levels of evidence for both safety and efficacy. OBJECTIVES In the present paper we critically reviewed literature data regarding the efficacy and safety of adjunctive agents in CLZ-resistan...
متن کاملنقص نظریهی ذهن در پسیکوز: آیا برای اسکیزوفرنیا اختصاصی است؟
AbstractObjectives: This project was implemented to compare the deficit patterns of Theory of Mind (TOM) in three groups of schizophrenic patients, psychotic manic patients, and normal subjects.Method: The subjects of the study comprised three groups of 19 patients with schizophrenia, 15 patients with psychotic mania, and 16 normal subjects. To assess TOM ability, collection of data was comple...
متن کامل